1. Home
  2. BOW vs CGEM Comparison

BOW vs CGEM Comparison

Compare BOW & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

HOLD

Current Price

$25.70

Market Cap

913.3M

Sector

Finance

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$15.95

Market Cap

780.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOW
CGEM
Founded
2020
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
913.3M
780.4M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
BOW
CGEM
Price
$25.70
$15.95
Analyst Decision
Buy
Strong Buy
Analyst Count
7
10
Target Price
$34.29
$28.80
AVG Volume (30 Days)
217.4K
770.4K
Earning Date
05-25-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
23.26
N/A
EPS
1.59
N/A
Revenue
$551,589,000.00
N/A
Revenue This Year
$12.33
N/A
Revenue Next Year
$17.20
N/A
P/E Ratio
$16.07
N/A
Revenue Growth
29.58
N/A
52 Week Low
$22.15
$5.68
52 Week High
$42.29
$16.74

Technical Indicators

Market Signals
Indicator
BOW
CGEM
Relative Strength Index (RSI) 54.16 76.32
Support Level $23.72 $6.75
Resistance Level $25.99 N/A
Average True Range (ATR) 1.20 1.02
MACD 0.18 0.30
Stochastic Oscillator 80.75 85.22

Price Performance

Historical Comparison
BOW
CGEM

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: